Detalhe da pesquisa
1.
Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial.
Lancet Oncol
; 19(6): 812-824, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29706375
2.
Factors influencing cervical cancer screening practice among female health workers in Nigeria: A systematic review.
Cancer Rep (Hoboken)
; 5(5): e1514, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34313402